Overview

Cellanome provides an automated platform designed to enhance the study of cell biology by allowing researchers to analyze individual cell behaviors, interactions, and functions under various conditions. The platform enables the performance of live cell phenotypic and functional assays, allowing scientists to observe how cells respond to different stimuli over time. This approach offers a more detailed and precise analysis compared to traditional methods that focus on bulk responses. Cellanome's service is tailored for research institutions, pharmaceutical companies, and biotech firms, generating revenue through subscriptions, licensing, and collaborations. The platform integrates easily into existing workflows, making it adaptable for various experimental setups. Cellanome aims to advance research in the life sciences and medical fields by providing a scalable and precise tool for exploring cellular behaviors.

Simplify's Take

What believers are saying

• Rising demand for personalized medicine aligns with Cellanome's focus on individual cell behaviors.
• Growing trend in microfluidics enhances Cellanome's scalable solutions for cell biology research.
• Collaborations with pharmaceutical companies offer opportunities for joint ventures and technology sharing.

What critics are saying

• Increased competition in single-cell analysis could impact Cellanome's market share.
• Ethical concerns about cellular manipulation may lead to regulatory challenges.
• Economic downturns could reduce demand for Cellanome's platform from research institutions.

What makes Cellanome unique

• Cellanome's platform offers unprecedented detail in individual cell behavior analysis.
• The company integrates seamlessly into existing workflows, enhancing research without major disruptions.
• Cellanome's focus on live cell assays provides a more granular analysis than traditional methods.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$201M

Above

Industry Average

Funded Over

2 Rounds

$150,000,000

Series B

Jan 2024

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$45M

$65M

$100M

$150M

View all funding stages